Phase III studies of brolucizumab versus aflibercept in nAMD: 48-week primary and key secondary outcomes from HAWK/HARRIER

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Jaffe, GJ; Koh, AHC; Ogura, Y; Weichselberger, A; Holz, FG; Dugel, PU

Published Date

  • July 1, 2018

Published In

Volume / Issue

  • 59 / 9

Published By

Pages

  • 5

Electronic International Standard Serial Number (EISSN)

  • 1552-5783

International Standard Serial Number (ISSN)

  • 0146-0404

Conference Name

  • Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)

Conference Location

  • Honolulu, HI

Conference Start Date

  • April 29, 2018

Conference End Date

  • May 3, 2018